Trials / Sponsors / Amplia Therapeutics Limited
Amplia Therapeutics Limited
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic C Pancreatic Cancer Metastatic | Phase 1 / Phase 2 | 2025-08-18 |
| Active Not Recruiting | ACCENT: AMP945 in Combination with Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer Pancreatic Cancer, PDAC, Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | 2022-05-31 |